Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03299543 · ClinicalTrials.gov registry record

Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate

A clinical trial of Ketosis, sponsored by Medamonitor.

Completed
Registry status
61
Enrollment target
1
Study location

NCT03299543 is a study of Ketosis that has completed, run by Medamonitor. The registered enrollment target is 61 participants, below the 116-participant average among 4 other Ketosis trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03299543, a study of Ketosis, has completed, sponsored by Medamonitor.

COMPLETED
Registry status
61 participants
Enrollment target
1
Study location

Study Summary

Subjects will provide blood and breath samples to evaluate the relationship between breath acetone and two blood-bound species: beta-hydroxybutyrate and glucose. Subjects will be asked to provide breath and blood samples at a baseline visit and second optional visit. The two visits will be spaced approximately 3 hours apart.

Conditions Studied

Interventions

  • DEVICE LEVL (Medamonitor)

Study Locations (1)

Washington

  • Medamonitor, LLC - Seattle

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2017-09-12
Est. Completion 2018-02-28

Sponsor

Medamonitor

1 total trials

What the Registry Record Tells You About NCT03299543

The ClinicalTrials.gov registry entry for NCT03299543 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 4 other Ketosis trials with a reported enrollment target (47% lower). The listed sponsor is Medamonitor, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ketosis appearing as the primary indexed condition, and to 1 intervention - of which LEVL (Medamonitor) is the first listed.

NCT03299543 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT03299543 about?

NCT03299543 is a clinical study titled "Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate". Subjects will provide blood and breath samples to evaluate the relationship between breath acetone and two blood-bound species: beta-hydroxybutyrate and glucose. Subjects will be asked to provide breath and blood samples at a baseline visit and second optional visit. The two visits will be spaced ap...

What is the current status of trial NCT03299543?

This trial is currently completed. The enrollment target is 61 participants. The study started on 2017-09-12. Estimated completion is 2018-02-28.

What conditions does trial NCT03299543 study?

This clinical trial studies the following conditions: Ketosis.

What interventions are being tested in trial NCT03299543?

The interventions under investigation include: LEVL (Medamonitor) (DEVICE).

Who is sponsoring clinical trial NCT03299543?

This trial is sponsored by Medamonitor, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03299543 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ketosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.